Daphne Quimi's Net Worth
$8.65 Million
Who is Daphne Quimi?
Daphne Quimi has an estimated net worth of $8.65 Million. This is based on reported shares across multiple companies, which include Amylyx Pharmaceuticals, Inc., AMICUS THERAPEUTICS, INC., and Century Therapeutics, Inc..
SEC CIK
Daphne Quimi's CIK is 0001543031
Past Insider Trading and Trends
2020 was Daphne Quimi's most active year for acquiring shares with 15 total transactions. Daphne Quimi's most active month to acquire stocks was the month of December. 2020 was Daphne Quimi's most active year for disposing of shares, totalling 21 transactions. Daphne Quimi's most active month to dispose stocks was the month of December. 2015 saw Daphne Quimi paying a total of $184,110.96 for 128,850 shares, this is the most they've acquired in one year. In 2023 Daphne Quimi cashed out on 69,112 shares for a total of $842,003.72, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Amylyx Pharmaceuticals, Inc. (AMLX) Snapshot price: $15.27
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
∞
| 5K |
$1.89 | $9,436.03 | 5K |
May 14 - May 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AMICUS THERAPEUTICS, INC. (FOLD) Snapshot price: $13.09
Chief Financial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -2.90% | -11.92K |
$12.79 | -$152,443.50 | 398.53K |
Scheduled
|
Jan 17 - Jan 18
| ||
Form 4
| +7.68% | 29.26K |
$12.02 | -$355,371.30 | 410.45K |
Jan 11
| |||
Form 4
| -1.01% | -3.88K |
$12.03 | -$46,724.52 | 381.2K |
Jan 4
| |||
Form 4
| +14.84% | 49.77K |
$12.11 | -$287,464.40 | 385.08K |
Jan 2 - Jan 3
| |||
Form 4
| -1.29% | -4.40K |
$11.29 | -$49,620.58 | 335.31K |
Scheduled
|
Sep 1
| ||
Form 4
| -1.68% | -5.80K |
$12.00 | -$69,576.00 | 339.71K |
Scheduled
|
Aug 5
| ||
Form 4
| -1.26% | -4.40K |
$9.00 | -$39,564.00 | 345.51K |
Scheduled
|
Jun 17
| ||
Form 4
| +5.42% | 18K |
$10.53 | -$198,416.79 | 349.9K |
Jan 14
| |||
Form 4
| +14.20% | 41.28K |
$11.69 | -$372,590.86 | 331.91K |
Dec 31 - Jan 4
| |||
Form 4
| +7.11% | 19.3K |
—
|
—
| 290.63K |
Apr 6
| |||
Form 4
| +4.61% | 11.96K |
$6.71 | $7.60 | 271.33K |
Mar 5
| |||
Form 4
| +1.86% | 4.73K |
$21.84 | -$104,152.95 | 259.37K |
Jan 15
| |||
Form 4
| +4.21% | 10.29K |
$23.09 | -$527,306.33 | 254.64K |
Dec 31 - Jan 4
| |||
Form 4
|
—
|
0
|
$13.52 | -$105,773.50 | 244.34K |
Scheduled
|
Dec 21
| ||
Form 4
| +11.99% | 26.16K |
$13.57 | $60.11 | 244.34K |
Dec 15
| |||
Form 4
| +5.31% | 11K |
$8.31 | -$28,449.00 | 218.18K |
Scheduled
|
Oct 1 - Oct 2
| ||
Form 4
| +6.69% | 13K |
$9.05 | -$54,271.97 | 207.18K |
Scheduled
|
Jul 1
| ||
Form 4
| -0.54% | -1.05K |
$11.14 | -$11,652.44 | 194.18K |
Jun 15
| |||
Form 4
| +2.52% | 4.8K |
—
|
—
| 195.22K |
Apr 1
| |||
Form 4
| +6.98% | 12.43K |
$9.46 | -$114,134.90 | 190.42K |
Jan 10
| |||
Form 4
| -2.19% | -3.98K |
$6.33 | -$118,944.06 | 177.99K |
Scheduled
|
Jan 9
| ||
Form 4
| -6.39% | -12.42K |
$9.39 | -$116,629.05 | 181.97K |
Jan 2 - Jan 3
| |||
Form 4
| +50.39% | 65.13K |
$9.74 | -$65,598.90 | 194.39K |
Dec 31 - Jan 2
| |||
Form 4
| -0.80% | -1.05K |
$11.35 | -$11,872.10 | 129.25K |
Jun 17
| |||
Form 4
| +10.47% | 12.35K |
—
|
—
| 130.3K |
Apr 11
| |||
Form 4
| +83.35% | 53.62K |
$10.33 | -$39,770.50 | 117.95K |
Jan 2 - Jan 3
| |||
Form 4
|
—
|
0
|
$10.48 | -$79,100.00 | 64.33K |
Scheduled
|
Mar 9
| ||
Form 4
|
—
|
0
|
$9.11 | -$80,636.80 | 64.33K |
Scheduled
|
Mar 1
| ||
Form 4
| +17.66% | 9.66K |
$15.67 | -$46,273.51 | 64.33K |
Jan 3
| |||
Form 4
|
—
|
0
|
$14.72 |
—
| 54.68K |
Scheduled
|
Jan 2
| ||
Form 4
|
—
|
0
|
$14.25 |
—
| 54.68K |
Scheduled
|
Oct 12
| ||
Form 4
| +126.04% | 30.49K |
—
|
—
| 54.68K |
Jan 3
| |||
Form 4
| -19.04% | -5.69K |
$8.00 | -$45,504.00 | 24.19K |
Scheduled
|
Nov 9
| ||
Form 4
| +39.76% | 8.5K |
—
|
—
| 29.88K |
Jun 15
| |||
Form 4
| +275.83% | 15.69K |
$9.03 | -$84,078.33 | 21.38K |
Jan 4
| |||
Form 4
|
—
|
0
|
$13.13 | $0.01 | 5.69K |
Scheduled
|
Oct 1
| ||
Form 4
| -30.53% | -2.50K |
$18.08 | -$45,200.00 | 5.69K |
Scheduled
|
Sep 14
| ||
Form 4
|
—
|
0
|
$13.98 |
—
| 8.19K |
Scheduled
|
Jul 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4
|
∞
| 8.19K |
$10.82 | -$181,875.60 | 8.19K |
Scheduled
|
May 8 - May 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
$8.00 |
—
| 50K |
Scheduled
|
Nov 25
| ||
Form 4
|
—
|
0
|
$7.00 |
—
| 50K |
Scheduled
|
Oct 3
| ||
Form 4
|
—
|
0
|
$6.10 |
—
| 50K |
Scheduled
|
Sep 29
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
∞
| 50K |
—
|
—
| 50K |
Apr 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4 - Jan 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Century Therapeutics, Inc. (IPSC) Snapshot price: $4.55
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||